HUP0303285A2 - Gyenge opioidok és vegyes opioid-agonisták/-antagonisták felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény elõállítására - Google Patents

Gyenge opioidok és vegyes opioid-agonisták/-antagonisták felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény elõállítására

Info

Publication number
HUP0303285A2
HUP0303285A2 HU0303285A HUP0303285A HUP0303285A2 HU P0303285 A2 HUP0303285 A2 HU P0303285A2 HU 0303285 A HU0303285 A HU 0303285A HU P0303285 A HUP0303285 A HU P0303285A HU P0303285 A2 HUP0303285 A2 HU P0303285A2
Authority
HU
Hungary
Prior art keywords
urinary incontinence
antagonists
preparing
pharmaceutical composition
opioid agonists
Prior art date
Application number
HU0303285A
Other languages
English (en)
Inventor
Thomas Christoph
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of HUP0303285A2 publication Critical patent/HUP0303285A2/hu
Publication of HUP0303285A3 publication Critical patent/HUP0303285A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

A találmány tárgya gyenge opioidok és vegyes opioid-agonisták/-antagonisták felhasználása megnövekedett vizelési inger, illetvevizeletinkontinencia kezelésére alkalmas gyógyszerek előállítására,továbbá a megfelelő gyógyszerek és eljárás megnövekedett vizelésiinger, illetve vizeletinkontinencia kezelésére. Ó
HU0303285A 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence HUP0303285A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10059415A DE10059415A1 (de) 2000-11-30 2000-11-30 Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz
PCT/EP2001/013911 WO2002043713A2 (de) 2000-11-30 2001-11-28 Verwendung von schwachen opioiden und gemischten opioidagonisten / -antagonisten zur therapie der harninkontinenz

Publications (2)

Publication Number Publication Date
HUP0303285A2 true HUP0303285A2 (hu) 2004-01-28
HUP0303285A3 HUP0303285A3 (en) 2005-05-30

Family

ID=7665212

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303285A HUP0303285A3 (en) 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence

Country Status (14)

Country Link
US (1) US7008939B2 (hu)
EP (1) EP1337254B1 (hu)
JP (1) JP2004527465A (hu)
AT (1) ATE287265T1 (hu)
AU (2) AU2073602A (hu)
CA (1) CA2430281C (hu)
DE (2) DE10059415A1 (hu)
ES (1) ES2234933T3 (hu)
HU (1) HUP0303285A3 (hu)
MX (1) MXPA03004713A (hu)
NZ (1) NZ526604A (hu)
PL (1) PL204246B1 (hu)
PT (1) PT1337254E (hu)
WO (1) WO2002043713A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476280B2 (en) 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
US7964315B2 (en) * 2003-09-12 2011-06-21 Bdf Ip Holdings Ltd. Shutdown methods and designs for fuel cell stacks
JP4902883B2 (ja) * 2005-03-11 2012-03-21 ビーディーエフ アイピー ホールディングス リミテッド 燃料電池スタックのシャットダウン方法および設計
TW200800223A (en) * 2005-12-21 2008-01-01 Shire Pharmaceuticals Inc Transdermal delivery of meptazinol
US8748448B2 (en) 2007-10-18 2014-06-10 Aiko Biotechnology Combination analgesic employing opioid agonist and neutral antagonist
WO2009051824A2 (en) * 2007-10-18 2009-04-23 Aiko Biotechnology Combination analgesic employing opioid and neutral antagonist
CN102836122A (zh) * 2011-06-24 2012-12-26 扬子江药业集团四川海蓉药业有限公司 含有盐酸美普他酚的组合物注射液及其制备方法
CN109646397A (zh) * 2015-02-13 2019-04-19 成都苑东生物制药股份有限公司 一种盐酸美普他酚注射液药物组合物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
USRE36547E (en) * 1992-09-21 2000-02-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
KR100341829B1 (ko) * 1996-03-08 2002-08-22 니코메드 덴마크 에이/에스 방출특성이변형된다-유니트투여량조성물
US5859043A (en) * 1996-06-11 1999-01-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for maintaining kidney function during surgery or severe trauma under general anesthesia
EP1005861B1 (en) * 1997-04-11 2005-06-29 Nippon Shinyaku Co., Ltd. Remedies for frequent urination and urinary incontinence
US5840696A (en) * 1997-09-11 1998-11-24 Lippton; Howard Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)
EP0913152B1 (de) * 1997-11-03 2001-12-19 Stada Arzneimittel Ag Stabilisiertes Kombinationsarzneimittel enthaltend Naloxone und ein Opiatanalgetikum
US6274591B1 (en) * 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
DE19947747A1 (de) * 1999-10-05 2001-04-12 Gruenenthal Gmbh Verwendung von (+)-Tramadol, O-Demethyltramadol bzw. (+)-O-Demethyltramadol zur Therapie der Harninkontinenz
US8410129B2 (en) * 2002-02-15 2013-04-02 Howard Brooks-Korn Treatment for paresis/paralysis

Also Published As

Publication number Publication date
CA2430281C (en) 2009-08-25
PL204246B1 (pl) 2009-12-31
EP1337254A2 (de) 2003-08-27
JP2004527465A (ja) 2004-09-09
WO2002043713A3 (de) 2002-10-31
HUP0303285A3 (en) 2005-05-30
US7008939B2 (en) 2006-03-07
NZ526604A (en) 2005-04-29
ES2234933T3 (es) 2005-07-01
WO2002043713A2 (de) 2002-06-06
DE10059415A1 (de) 2002-06-06
AU2073602A (en) 2002-06-11
EP1337254B1 (de) 2005-01-19
AU2002220736B2 (en) 2006-04-06
PT1337254E (pt) 2005-05-31
US20040029905A1 (en) 2004-02-12
ATE287265T1 (de) 2005-02-15
MXPA03004713A (es) 2003-08-19
DE50105150D1 (de) 2005-02-24
PL363677A1 (en) 2004-11-29
CA2430281A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
WO2005107726A3 (en) Method for the treatment of back pain
HUP0001089A2 (hu) Gyógyászati készítmények férfiak erekciós zavarainak kezelésére
BR0212714A (pt) Combinação de opiáceos selecionados com antagonistas muscarìnicos destinados ao tratamento da incontinência urinária
BR0010061A (pt) Tratamento de fibrose por antagonista de il-13 e cadeias de receptor il-13
MXPA05010819A (es) Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
NZ595262A (en) Use of il-23 and il-27 antagonists to treat autoimmune ocular inflammatory disease
HUP0400782A2 (hu) Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények
PL1730147T3 (pl) Podstawowe związki 1,4,8-triazaspiro[4.5]dekan-2-onu
HUP0301122A2 (hu) Gyógyszerkombinációk és gasztrointesztinális rendellenességek kezelésében való alkalmazásuk
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
HUP0101546A2 (hu) Opioid antagonistát és NMDA-receptor komplex modulátort tartalmazó gyógyászati készítmény alkohol- és drogfüggőség kezelésére
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
MY133995A (en) 6-phenylpyrrolopyrimidinedione derivatives
ATE404211T1 (de) Xenon als nmda-antogonist zur neuroprotektion
HUP0303285A2 (hu) Gyenge opioidok és vegyes opioid-agonisták/-antagonisták felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény elõállítására
MXPA01008993A (es) Tratamiento de combinacion para depresion y ansiedad.
GB0507598D0 (en) Composition
PT1255538E (pt) Utilizacao do acido 2-metil-tiazolidin-2,4-dicarboxilico e/ou sais compativeis fisiologicamente para tratamento e/ou prevencao de cancros
HUP0302984A2 (hu) Buprenorphin felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
AU2002220736A1 (en) Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
WO2002069944A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.
PT1572686E (pt) Derivados de amida do ácido antranílico e suas utilizações farmacêuticas
EP1260221A3 (en) Combination treatment for depression and anxiety

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished